Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hong Lv
Observed names:
H. Lv,
Lv, Hong
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0009-0000-9602-2391
Observed ORCID:
0009-0000-9602-2391
OpenAlex ID:
A5064551206
ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis.
2023
·
Yueping Liu
, Hong Lv
, et al.
·
Journal of Clinical Oncology
·
4
Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer
2026
·
Xiang-Rong Wu
, Hong Lv
, et al.
·
Signal Transduction and Targeted Therapy
·
3
PDF
Abstract P2-13-11: Response to anti-HER2 neoadjuvant chemotherapy in invasive breast cancers with different HER2 FISH-positive patterns
2022
·
Hong Lv
, Qian-Ming Bai
, et al.
·
Cancer Research
·
1
168 The Mutational Landscape of the PI3K/AKT Pathway in Invasive Lobular Carcinoma and Its Association with Clinicopathological Features
2026
·
Ming Li
, Hong Lv
, et al.
·
Laboratory Investigation
173 Primary Breast Desmoid Fibromatosis with an Indolent Biological Behavior: A Clinicopathologic Study of 56 Cases
2026
·
Hong Lv
, Ruohong Shui
, et al.
·
Laboratory Investigation
167 Quantitative HER2 mRNA by RNAscope: Correlation with IHC and Utility for HER2 Assessment in Breast Cancer
2026
·
Ming Li
, Baohui Yue
, et al.
·
Laboratory Investigation
228 Clinicopathological Features and Outcomes of Malignant Adenomyoepithelioma of the Breast: Experience from a single institution
2026
·
Xiaoli Xu
, Linrong Li
, et al.
·
Laboratory Investigation
PDF
244 Camrelizumab-Associated Reactive Capillary Endothelial Proliferation in Breast Cancer: Clinicopathological Features and Diagnostic Challenges
2026
·
Ke Zuo
, Ming Li
, et al.
·
Laboratory Investigation
241 A Portrait of TERT Promoter Mutations in Breast Cancer: Genomic Features and Clinicopathologic Correlates
2026
·
Shuling Zhou
, Mengyuan Cai
, et al.
·
Laboratory Investigation
Abstract PS3-06-09: Her2-ladder: a spatially interpretable artificial intelligence-driven model for tailored dual-targeted therapy in HER2-positive breast cancer
2026
·
X. Wu
, D. Ma
, et al.
·
Clinical Cancer Research
275 Genetic Profiling of Metaplastic Breast Cancer with TERT Promoter Mutation
2025
·
Shuling Zhou
, Hong Lv
, et al.
·
Laboratory Investigation
PDF
202 The Impact of Tumor-infiltrating Lymphocytes on The Efficacy of HER2-Targeted Monotherapy and Dual HER2-targeted Therapy
2025
·
Hong Lv
, Ming Li
, et al.
·
Laboratory Investigation
Show more works
View as search
Works count:
21
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type